Pleomorphic xanthoastrocytoma of the spinal cord: case report and literature review

被引:13
作者
Das, Sumit [1 ]
Yip, Stephen [2 ]
Hukin, Juliette [3 ]
Cochrane, Douglas [4 ]
Dunham, Christopher [1 ]
机构
[1] Univ British Columbia, Childrens & Womens Hlth Ctr British Columbia, Dept Pathol & Lab Med, Div Anat Pathol, Vancouver, BC V5Z 1M9, Canada
[2] Vancouver Gen Hosp, Dept Pathol & Lab Med, Vancouver, BC, Canada
[3] Childrens & Womens Hlth Ctr British Columbia, BMT, Dept Pediat, Div Pediat Neurol & Oncol Hematol, Vancouver, BC, Canada
[4] Univ British Columbia, Childrens & Womens Hlth Ctr British Columbia, Dept Surg, Div Pediat Neurosurg, Vancouver, BC V5Z 1M9, Canada
关键词
pleomorphic xanthoastrocytoma; pediatrics; spinal cord; BRAF V600E; BRAF; MUTATIONS; CHILDREN; TUMORS;
D O I
10.5414/NP300689
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Pleomorphic xanthoastrocytoma (PXA) is a rare slow-growing neoplasm that has predilection for the supratentorial comparment and the temporal lobe. Children and young adults are most frequently affected and they usually present with medically refractory seizures. PXAs involving the spinal cord have been rarely documented. We describe a 15-year-old boy who presented with shoulder/neck pain and upper extremity numbness/weakness. Neuroimaging revealed a solid, contrast enhancing, and intramedullary C5 - C6 mass. Microscopy demonstrated a typical WHO grade II PXA. Molecular testing did not reveal a BRAF V600E, IDH1 R132H, or IDH2 R172H mutation. Two years after a near total resection, significant tumor progression was noted via neuroimaging. To the authors' knowledge, this is the first description of the molecular characteristics of a spinal cord PXA.
引用
收藏
页码:190 / 196
页数:7
相关论文
共 22 条
[1]   Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients [J].
Boussemart, L. ;
Routier, E. ;
Mateus, C. ;
Opletalova, K. ;
Sebille, G. ;
Kamsu-Kom, N. ;
Thomas, M. ;
Vagner, S. ;
Favre, M. ;
Tomasic, G. ;
Wechsler, J. ;
Lacroix, L. ;
Robert, C. .
ANNALS OF ONCOLOGY, 2013, 24 (06) :1691-1697
[2]   Salvage therapy with BRAF inhibitors for recurrent pleomorphic xanthoastrocytoma: a retrospective case series [J].
Chamberlain, Marc C. .
JOURNAL OF NEURO-ONCOLOGY, 2013, 114 (02) :237-240
[3]   BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic Implications [J].
Dias-Santagata, Dora ;
Lam, Quynh ;
Vernovsky, Kathy ;
Vena, Natalie ;
Lennerz, Jochen K. ;
Borger, Darrell R. ;
Batchelor, Tracy T. ;
Ligon, Keith L. ;
Iafrate, A. John ;
Ligon, Azra H. ;
Louis, David N. ;
Santagata, Sandro .
PLOS ONE, 2011, 6 (03)
[4]   Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas [J].
Ellezam, Benjamin ;
Theeler, Brett J. ;
Walbert, Tobias ;
Mammoser, Aaron G. ;
Horbinski, Craig ;
Kleinschmidt-DeMasters, Bette K. ;
Perry, Arie ;
Puduvalli, Vinay ;
Fuller, Gregory N. ;
Bruner, Janet M. ;
Aldape, Kenneth D. .
ACTA NEUROPATHOLOGICA, 2012, 124 (03) :449-451
[5]  
Fouladi M, 2001, NEURO-ONCOLOGY, V3, P184, DOI 10.1093/neuonc/3.3.184
[6]   Primary spinal pleomorphic xanthoastrocytoma [J].
Gill, Maneet ;
Pathak, H. C. ;
Madan, Renu ;
Bhattacharya, S. ;
Choudhary, G. S. .
NEUROLOGY INDIA, 2010, 58 (05) :771-773
[7]   OUTCOME OF CHILDREN WITH PRIMARY INTRAMEDULLARY SPINAL-CORD TUMORS [J].
HARDISON, HH ;
PACKER, RJ ;
RORKE, LB ;
SCHUT, L ;
SUTTON, LN ;
BRUCE, DA .
CHILDS NERVOUS SYSTEM, 1987, 3 (02) :89-92
[8]   PLEOMORPHIC XANTHOASTROCYTOMA IN THE SPINAL-CORD [J].
HERPERS, MJHM ;
FRELING, G ;
BEULS, EAM .
JOURNAL OF NEUROSURGERY, 1994, 80 (03) :564-569
[9]   To BRAF or Not to BRAF: Is That Even a Question Anymore? [J].
Horbinski, Craig .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2013, 72 (01) :2-7
[10]  
KEPES JJ, 1979, CANCER-AM CANCER SOC, V44, P1839, DOI 10.1002/1097-0142(197911)44:5<1839::AID-CNCR2820440543>3.0.CO